RXSIGHT INC (RXST)

US78349D1072 - Common Stock

60.65  -1.61 (-2.59%)

After market: 60.65 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to RXST. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 72.13. This target is 18.93% above the current price.
RXST was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about RXST.
In the previous month the buy percentage consensus was at a similar level.
RXST was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 60.6563.6373.4472.1378.75 - 4.91% 21.09% 18.93% 29.84%
Up and Down Grades
Date Firm Action Rating
2024-05-07 BTIG Maintains Buy -> Buy
2024-05-07 Needham Maintains Buy -> Buy
2024-05-07 Oppenheimer Maintains Outperform -> Outperform
2024-05-07 Wells Fargo Maintains Overweight -> Overweight
2024-05-06 Stifel Maintains Buy -> Buy
2024-04-11 Needham Reiterate Buy -> Buy
2024-02-29 Needham Maintains Buy -> Buy
2024-02-29 Oppenheimer Maintains Outperform -> Outperform
2024-02-29 Stifel Maintains Buy -> Buy
2024-02-29 JP Morgan Maintains Overweight -> Overweight
2024-02-12 Stifel Maintains Buy -> Buy
2024-01-29 Oppenheimer Maintains Outperform -> Outperform
2024-01-16 Oppenheimer Maintains Outperform -> Outperform
2024-01-08 Needham Maintains Buy -> Buy
2024-01-08 Oppenheimer Maintains Outperform -> Outperform
2023-12-13 Wells Fargo Upgrade Equal-Weight -> Overweight
2023-12-12 Stifel Initiate Buy
2023-12-04 Morgan Stanley Initiate Overweight
2023-11-10 Needham Maintains Buy -> Buy
2023-08-08 Needham Reiterate Buy -> Buy
2023-08-08 Oppenheimer Maintains Outperform -> Outperform
2023-07-12 Needham Maintains Buy -> Buy
2023-06-05 BTIG Maintains Buy -> Buy
2023-06-05 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-05-10 Needham Maintains Buy -> Buy
2023-05-10 Wells Fargo Maintains Equal-Weight
2023-04-19 Needham Maintains Buy
2023-04-13 Oppenheimer Initiate Outperform
2023-03-07 Needham Reiterate Buy
2023-03-07 JP Morgan Maintains Overweight